Active Ingredient(s): Lesinurad
FDA Approved: * December 22, 2015
Category: Gout

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zurampic Overview

Lesinurad (brand name Zurampic) is a urate transporter inhibitor for treating high blood uric acid levels associated with gout.[1] It is only recommended together with either allopurinol or febuxostat when these medications are not sufficient.[2] It received FDA approval on 22 December 2015.[2] The European Commission granted a marketing authorisation valid throughout the European Union on 18 February 2016.[3] In February 2019, i...

Read more Zurampic Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lesinurad

Recent Zurampic Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zurampic: (2 results)

Sorted by National Drug Code
  • 0310-1475 Zurampic 200 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
  • 70785-011 Zurampic 200 mg Oral Tablet, Film Coated by Ironwood Pharmaceuticals, Inc.

Other drugs which contain Lesinurad or a similar ingredient: (3 results)